GT200100099A - Derivados de higromicina a. - Google Patents

Derivados de higromicina a.

Info

Publication number
GT200100099A
GT200100099A GT200100099A GT200100099A GT200100099A GT 200100099 A GT200100099 A GT 200100099A GT 200100099 A GT200100099 A GT 200100099A GT 200100099 A GT200100099 A GT 200100099A GT 200100099 A GT200100099 A GT 200100099A
Authority
GT
Guatemala
Prior art keywords
derivatives
infections
hygromycin
hygromycin derivatives
refers
Prior art date
Application number
GT200100099A
Other languages
English (en)
Inventor
Matthew Merrill Hayward
Robert Gerald Linde Ii
Takushi Kaneko
Michael Scott Visser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200100099A publication Critical patent/GT200100099A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS DERIVADOS DE HIGROMICINA A, QUE SON UTILES COMO AGENTES ANTIBACTERIANOS Y ANTIPROTOZOARIOS QUE PUEDEN USARSE PARA TRATAR DIVERSAS INFECCIONES BACTERIANAS Y PROTOZOARIAS Y TRSTORNOS RELACIONADOS CON TALES INFECCIONES. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE LOS DERIVADOS DE LA HIGROMICINA A Y A PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS Y PROTOZORIAS MEDIANTE LA ADMINISTRACION DE DERIVADOS DE LA HIGROMICINA A.
GT200100099A 2000-06-02 2001-05-30 Derivados de higromicina a. GT200100099A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20902300P 2000-06-02 2000-06-02

Publications (1)

Publication Number Publication Date
GT200100099A true GT200100099A (es) 2002-01-31

Family

ID=22777009

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200100099A GT200100099A (es) 2000-06-02 2001-05-30 Derivados de higromicina a.

Country Status (31)

Country Link
US (1) US6867230B2 (es)
EP (1) EP1287011A1 (es)
JP (1) JP2003535100A (es)
KR (1) KR20030010655A (es)
CN (1) CN1432019A (es)
AP (1) AP2002002669A0 (es)
AR (1) AR028667A1 (es)
AU (1) AU2001260528A1 (es)
BG (1) BG107265A (es)
BR (1) BR0111242A (es)
CA (1) CA2410643A1 (es)
CZ (1) CZ20023859A3 (es)
EA (1) EA200201167A1 (es)
EC (1) ECSP014093A (es)
EE (1) EE200200671A (es)
GT (1) GT200100099A (es)
HU (1) HUP0302263A2 (es)
IL (1) IL152984A0 (es)
IS (1) IS6618A (es)
MA (1) MA26909A1 (es)
MX (1) MXPA02011966A (es)
NO (1) NO20025704L (es)
OA (1) OA12277A (es)
PA (1) PA8518101A1 (es)
PE (1) PE20020334A1 (es)
PL (1) PL359179A1 (es)
SK (1) SK16612002A3 (es)
SV (1) SV2002000474A (es)
TN (1) TNSN01080A1 (es)
UY (1) UY26741A1 (es)
WO (1) WO2001092280A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4488350B2 (ja) * 2002-05-16 2010-06-23 セプラコール インク． 哺乳類アナンダミド輸送体を阻害するアミン、およびその使用方法
EP3840743A4 (en) * 2018-08-20 2022-08-17 Northeastern University HYGROMYCIN A COMPOUNDS AND METHODS OF TREATING SPIROCHETE DISEASES
CU20180159A7 (es) * 2018-12-28 2020-10-20 Chengdu Olisynn Biotechnology Co Ltd Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1234567A (en) * 1915-09-14 1917-07-24 Edward J Quigley Soft collar.
US2004123A (en) * 1934-02-15 1935-06-11 Jr Robert B Loibl Pest exterminator
ID27030A (id) * 1998-05-04 2001-02-22 Pfizer Prod Inc Turunan-turunan higromisin a
SK16442000A3 (sk) * 1998-05-04 2001-07-10 Pfizer Products Inc. Deriváty 2''-deoxy-hygromycínu
EA004303B1 (ru) * 1998-12-02 2004-02-26 Пфайзер Продактс Инк. Производные гигромицина а в качестве антибактериальных агентов
PL357083A1 (en) * 1999-10-29 2004-07-12 Pfizer Products Inc. Hygromycin derivatives
US7654321B2 (en) * 2006-12-27 2010-02-02 Schlumberger Technology Corporation Formation fluid sampling apparatus and methods

Also Published As

Publication number Publication date
IL152984A0 (en) 2003-06-24
OA12277A (en) 2006-05-11
IS6618A (is) 2002-11-14
SV2002000474A (es) 2002-07-03
CA2410643A1 (en) 2001-12-06
SK16612002A3 (sk) 2004-04-06
KR20030010655A (ko) 2003-02-05
EP1287011A1 (en) 2003-03-05
AR028667A1 (es) 2003-05-21
MA26909A1 (fr) 2004-12-20
EA200201167A1 (ru) 2003-06-26
HUP0302263A2 (hu) 2003-10-28
CN1432019A (zh) 2003-07-23
ECSP014093A (es) 2002-01-25
AP2002002669A0 (en) 2002-12-31
JP2003535100A (ja) 2003-11-25
NO20025704D0 (no) 2002-11-27
BR0111242A (pt) 2003-06-03
AU2001260528A1 (en) 2001-12-11
WO2001092280A1 (en) 2001-12-06
BG107265A (bg) 2003-07-31
US6867230B2 (en) 2005-03-15
PE20020334A1 (es) 2002-04-30
CZ20023859A3 (cs) 2004-02-18
PL359179A1 (en) 2004-08-23
EE200200671A (et) 2004-08-16
NO20025704L (no) 2002-11-27
MXPA02011966A (es) 2003-04-22
US20030045528A1 (en) 2003-03-06
PA8518101A1 (es) 2002-09-17
UY26741A1 (es) 2001-12-28
TNSN01080A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
PA8486001A1 (es) Composiciones de celecoxib
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
UY26130A1 (es) Compuestos para tratar la obesidad
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
PA8591701A1 (es) Derivados de pirrolopirimidina
PA8489501A1 (es) Antibioticos cetolidos
UY25780A1 (es) Nuevos antibióticos macrólidos
HN1999000080A (es) Derivados de isotiazol utiles como agentes anticancerosos.
BRPI0607926A2 (pt) compostos espiro-oxindol e seus usos como agentes terapêuticos
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
PA8548401A1 (es) Agentes antibacterianos
GT200000077A (es) Sal mutua de amlodipino y atorvastatina
UY26889A1 (es) Compuestos farmacéuticos
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
SE9901077D0 (sv) Novel use
PA8471801A1 (es) Derivados de higromicina a
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
GT200100099A (es) Derivados de higromicina a.
PA8471901A1 (es) Derivados de 2"-desoxi higromicina
GT199600072A (es) Formas zwitterionicas de trovafloxacina.
SV2002000210A (es) Profarmacos de higromicina a ref. pc10548ajnm/bb
SE0001631D0 (sv) New use
PA8505601A1 (es) Profarmacos de higromicina a
GT199600061A (es) Polimorfos de profarmaco de 6-n- (l-ala-l-ala)-trovafloxacina.